The role of ZAK following doxorubicin and fisetin treatment induces human osteosarcoma cell apoptosis
博士 === 中國醫藥大學 === 老化醫學博士學位學程 === 106 === part I Human osteosarcoma is a malignant cancer of the bone. It exhibits a characteristic malignant osteoblastic transformation and produces a diseased osteoid. A previous study demonstrated that doxorubicin chemotherapy decreases human osteosarcoma cell prol...
Main Authors: | Chien-Yao Fu, 傅建堯 |
---|---|
Other Authors: | Chih‐Yang Huang |
Format: | Others |
Language: | zh-TW |
Published: |
2018
|
Online Access: | http://ndltd.ncl.edu.tw/handle/885uqa |
Similar Items
-
Selective Activation of ZAK β Expression by 3-Hydroxy-2-Phenylchromone Inhibits Human Osteosarcoma Cells and Triggers Apoptosis via JNK Activation
by: Chien-Yao Fu, et al.
Published: (2020-05-01) -
The Molecular Mechanisms of Fisetin Combination of Sorafenib Induces Apoptosis in Human Cervical Cancer
by: Chih-Chien Wu, et al.
Published: (2015) -
The Roles of p53 and Securin on Fisetin-induced Apoptosis in Human Colorectal Cancer Cells
by: Sz-Hsien Yu, et al. -
Novel roles of ZAK alternative splicing isoforms, ZAKα and ZAKβ, in neoplastic cell transformation
by: Jin-Sun Lee, et al.
Published: (2017) -
Fisetin, a dietary flavonoid induces apoptosis via modulating the MAPK and PI3K/Akt signalling pathways in human osteosarcoma (U-2 OS) cells
by: Jian-Ming Li, et al.
Published: (2015-10-01)